[TCL1-family negative T-cell prolymphocytic leukemia with rapid progression of extranodal disease despite a normal white blood cell count].

Extranodal involvement Normal white blood cell count TCL1-family negative T-cell prolymphocytic leukemia

Journal

[Rinsho ketsueki] The Japanese journal of clinical hematology
ISSN: 0485-1439
Titre abrégé: Rinsho Ketsueki
Pays: Japan
ID NLM: 2984782R

Informations de publication

Date de publication:
2024
Historique:
medline: 4 7 2024
pubmed: 4 7 2024
entrez: 3 7 2024
Statut: ppublish

Résumé

Here we describe the case of a 69-year-old man who was found to have moderate thrombocytopenia and severe splenomegaly during a medical checkup at the age of 67. At the first visit, his white blood cell (WBC) count was 7,400/µl with 80% lymphocytes, and bone marrow aspiration showed 24% atypical lymphocytes. Flow cytometry of atypical lymphocytes was positive for mature T-cell markers, and T-cell clonality was revealed by T-cell receptor gene rearrangement. TCL1 was negative on immunohistochemistry. We diagnosed TCL1-family negative T-cell prolymphocytic leukemia (T-PLL) and employed watchful waiting. Thirty months after diagnosis, the patient developed urinary retention and right lower-limb paresis despite a normal WBC count, and an extradural tumor around the thoracic vertebrae and spinal cord compression were detected. The tumor was diagnosed as extranodal involvement of TCL1-family negative T-PLL, but the patient's general condition deteriorated rapidly, and no treatment was possible. T-PLL is a rare disease characterized by leukocytosis, and the WBC count generally increases with disease progression. Although blood counts are recommended for observation, it is important to keep in mind that the disease may worsen even if blood counts do not change.

Identifiants

pubmed: 38960645
doi: 10.11406/rinketsu.65.487
doi:

Substances chimiques

Proto-Oncogene Proteins 0
TCL1A protein, human 0

Types de publication

Journal Article Case Reports

Langues

jpn

Sous-ensembles de citation

IM

Pagination

487-491

Auteurs

Misayo Shimizu (M)

Hematology and Oncology Division, Hitachi General Hospital.

Yuri Tsuboi (Y)

Hematology and Oncology Division, Hitachi General Hospital.

Akihiro Kuroda (A)

Hematology and Oncology Division, Hitachi General Hospital.

Masanori Seki (M)

Hematology and Oncology Division, Hitachi General Hospital.

Atsushi Shinagawa (A)

Hematology and Oncology Division, Hitachi General Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH